347850 fundamentals
An in-depth look to D&D PHARMATECH INC. operating, investing, and financing activities
347850 free cash flow for Q3 24 is -5.26 B KRW. For 2023, 347850 free cash flow was -9.16 B KRW and operating cash flow was -9.12 B KRW.
Q2 '23
Q3 '23
Q2 '24
Q3 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: KRW
Q2 '23
Q3 '23
Q2 '24
Q3 '24
TTM